However, the inherent complexity of TM, characterized by an abundance of bioactive constituents and synergistic effects, present significant challenges for mechanistic characterisation, standardization, and clinical authentication
Meanwhile, Luciferase activity assays revealed no significant difference in GGCT promoter activity between Gln+ and Gln- groups, indicating that Gln does not directly regulate GGCT transcription (Fig
Cardioprotective Effects of Corilagin on Doxorubicin induced Cardiotoxicity via P13K/Akt and NF-B Signaling Pathways in a Rat Model
L-Carnitine Market Size, Share & Trends Analysis Report By Process (Chemical Synthesis, Bioprocess), By Products (Food and Pharma Grade, Feed Grade), By Applications (Animal Feed, Healthcare Products, Functional Food and Beverages, Medicines) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034 Last Updated: June 03, 2026 | Author: Anantika Sharma | Format: | Report Code: SR3369DR | Pages: 110 L-Carnitine Market Size The global l-carnitine market size was valued at USD 212.7 million in 2025 and is projected to grow from USD 222.69 million in 2026 to USD 321.58 million by 2034 at a CAGR of 4.7% during the forecast period 2026-2034
